Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s share price reached a new 52-week low during trading on Tuesday . The company traded as low as $3.19 and last traded at $3.23, with a volume of 5491 shares. The stock had previously closed at $3.24.
Hypera Price Performance
The business has a 50 day moving average price of $4.20 and a 200 day moving average price of $4.91. The firm has a market capitalization of $2.05 billion, a P/E ratio of 5.89 and a beta of 1.02.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
- Five stocks we like better than Hypera
- Industrial Products Stocks Investing
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- Netflix Is On Track To Hit $1,000 By Christmas
- What Does a Stock Split Mean?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
